[可修改的糖尿病病危险因素的证据图的构建]
1Department of Disability Prevention Research, China Rehabilitation Science Institute, Beijing 100068, China.
Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi
|December 24, 2025
概括
密集的血糖控制和合理的药物使用显著降低了糖尿病病 (DN) 的风险. 对高风险人群来说,监测高血压,视网膜病变,抑郁和肥胖是至关重要的.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 内分泌学 在内分泌学.
- 公共卫生 公共卫生
背景情况:
- 糖尿病病 (DN) 是一个主要的全球健康问题,也是末期病的主要原因.
- 许多非遗传性DN风险因素已被提出,但它们的流行病学可靠性需要进行系统的评估.
研究的目的:
- 提供与糖尿病病发展相关的可修改风险因素的最高质量的证据.
- 评估各种DN风险因素的流行病学可靠性.
主要方法:
- 在2023年6月之前发布的关于DN风险因素的现有元分析的系统审查和元分析.
- 搜索了PubMed,科克兰图书馆,CNKI和万芳数据库.
- 评估了效应大小,置信区间,异质性,小研究效应和偏差,对证据可靠性进行分级.
主要成果:
- 有令人信服的证据 (I级) 将持续瘤亡因子受体-1 (TNFR-1),高TNFR-1/TNFR-2水平,Helicobacter pylori感染,高血压和密集的血糖控制与DN风险联系起来.
- 强烈暗示性证据 (II级) 涉及较高的HbA1c变异性,连续的TNFR-2,较高的胆红素总量,抑郁症,增加的腰围/肥胖,以及使用ACE抑制剂.
- 关键的危险因素包括血尿酸升高,血清氨酸C高,维生素D缺乏,糖尿病视网膜病变以及内脏脂肪面积增加. -葡萄糖共运输体2抑制剂显示出一种保护性关联.
结论:
- 密集的血糖管理和适当的药物使用对于降低DN风险至关重要.
- 密切监测诸如高血压,糖尿病视网膜病变,抑郁症和肥胖等并发症至关重要.
- 对于高风险个体,建议定期监测和控制相关血清生物标志物.
相关概念视频
Chronic Kidney Disease I: Introduction
536
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
536
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
166
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
166
Coronary Artery Disease I: Introduction
846
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
846
Pathophysiology of Diabetes
3.1K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.1K
Chronic Kidney Disease II: Clinical Manifestations
520
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
520
Chronic Kidney Disease III: Interprofessional Care
319
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
319


